Clinical Trials on Intraosseous Access in Switzerland
Total 18 results
-
The University of QueenslandAustralasian Kidney Trials NetworkCompletedVascular Access Complication | Hemodialysis Access Failure (Disorder)Netherlands, Switzerland, Canada, France, United Kingdom, Australia, Malaysia
-
University of LausanneCentre Hospitalier Universitaire VaudoisCompletedChemotherapy | Long Term Antibiotics | Total Parenteral Nutrition | Central Venous AccessSwitzerland
-
IGLESIAS Juan FernandoUniversity of BernRecruitingVascular Access Site OcclusionSwitzerland, Greece, Italy, Belgium
-
University of LuganoCompletedGroup 1 (Control): Access to a Static Version of the Website Containing Only Static Features (i.e. Library, First Aid, and FAQ) | Group2 (Intervention) Access to an Interactive Version of the Website Containing Both Static and Interactive FeaturesSwitzerland
-
Salah D. Qanadli, MD, PhDCompletedPain, Postoperative | Anxiety Postoperative | Vascular Access Site PainSwitzerland
-
IRCCS San RaffaeleCompletedSurgical and the Percutaneous Approach to the Upper Extremity AccessSpain, Sweden, Austria, Belgium, Germany, Switzerland, Italy, United States, France, United Kingdom
-
University Hospital, GenevaRecruiting
-
Schulthess KlinikCompletedDevice Success Rate | Device PerformanceSwitzerland, Austria
-
Cendres+MétauxTerminatedHemodialysis Access Failure (Disorder) | End-Stage Renal Disease Requiring HaemodialysisSwitzerland
-
Biotronik AGCompletedPeripheral Artery Disease | Access Site Complication | Outpatient TreatmentFrance, Austria, Belgium, Switzerland
-
University Hospital Inselspital, BerneCompletedEvaluation of Success Rate | Airway Leak Pressure | Side Effects of LMA Supreme in Pediatric Patients Undergoing General AnesthesiaSwitzerland
-
Universitätsklinikum Hamburg-EppendorfAarhus University Hospital; Academisch Medisch Centrum - Universiteit van Amsterdam... and other collaboratorsTerminatedComparison of Short- Term Success Rates of POEM With LHM | Comparison of Long-term Success Rates of POEM With LHMDenmark, Germany, Netherlands, Switzerland
-
Triemli HospitalCompletedEndocarditis | Aortic Aneurysm | Aortic Dissection | Valve Heart Disease | Root AbscessSwitzerland
-
University of BernNot yet recruitingComplications | Patient Reported Outcome Measures | Cost-Benefit Analysis | Cost-effectiveness | Esthetic Zone | Single Tooth Dental Implant | Single Tooth Lost | Accuracy of Dental Implants | Dimensional Changes | Implant Survival and Success | Frequency of Treatment ProtocolSwitzerland
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedCholecystitis | Appendicitis | Diverticulitis | Intra-Abdominal Abscess | Intra-Abdominal Infection | PeritonitisItaly, Spain, China, France, Switzerland, Australia, Denmark, Finland, Germany, Greece, Hong Kong, India, Philippines, Portugal, Saudi Arabia, South Africa, Taiwan, Turkey, United Kingdom
-
Onconova Therapeutics, Inc.TerminatedMyelodysplastic Syndrome | MDS | Refractory Anemia With Excess Blasts | RAEBUnited States, Spain, Canada, France, Australia, Switzerland, Israel, Japan, Belgium, India, Ireland, United Kingdom, Croatia, Czechia, Poland, Estonia, Germany, Italy, Austria, Hungary, Russian Federation, Sweden
-
Stichting Hemato-Oncologie voor Volwassenen NederlandDeutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)RecruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2Australia, Austria, Belgium, Estonia, Finland, France, Germany, Ireland, Lithuania, Luxembourg, Netherlands, Norway, Spain, Sweden, Switzerland
-
Stichting Hemato-Oncologie voor Volwassenen NederlandAstellas Pharma Global Development, Inc.; Deutsch-Österreichische Studiengruppe...Active, not recruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2Netherlands, Belgium, Germany, Switzerland, Australia, Finland, Norway, Sweden, Austria, France, Ireland, Lithuania, Luxembourg, Spain